ArticleArthritis & rheumatology (Hoboken, N.J.)2021

Validation of a Bioassay for Predicting Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis.

Ching-Huang Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.